Showing 1 - 10 results of 10 for search 'Mark A. Schroeder', query time: 0.07s
Refine Results
-
1
Mouse models of graft-versus-host disease: advances and limitations by Mark A. Schroeder, John F. DiPersio
Published 2011-05-01
Article -
2
-
3
The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era... by Lawrence W. Liu, Mei Wang, Nikhil Grandhi, Mark A. Schroeder, Theodore Thomas, Kristin Vargo, Feng Gao, Kristen M. Sanfilippo, Su-Hsin Chang
Published 2024-01-01
Article -
4
-
5
The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme. by Enfeng Wang, Chunyang Zhang, Navatha Polavaram, Fengming Liu, Gang Wu, Mark A Schroeder, Julie S Lau, Debabrata Mukhopadhyay, Shi-Wen Jiang, Brian Patrick O'Neill, Kaustubh Datta, Jinping Li
Published 2014-01-01
Article -
6
Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues by Dan Zhou, Bonnie M. Alver, Shuang Li, Ryan A. Hlady, Joyce J. Thompson, Mark A. Schroeder, Jeong-Heon Lee, Jingxin Qiu, Philip H. Schwartz, Jann N. Sarkaria, Keith D. Robertson
Published 2018-03-01
Article -
7
Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins by Gaspar J. Kitange, Ann C. Mladek, Mark A. Schroeder, Jenny C. Pokorny, Brett L. Carlson, Yuji Zhang, Asha A. Nair, Jeong-Heon Lee, Huihuang Yan, Paul A. Decker, Zhiguo Zhang, Jann N. Sarkaria
Published 2016-03-01
Article -
8
Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide by Scott R. Goldsmith, Michael Slade, John F. DiPersio, Peter Westervelt, Steven J. Lawrence, Geoffrey L. Uy, Camille N. Abboud, Ravi Vij, Mark A. Schroeder, Todd A. Fehniger, Erik R. Dubberke, Kathryn Trinkaus, Rizwan Romee
Published 2016-11-01
Article -
9
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia by Ramzi Abboud, Ezhilarasi Chendamarai, Michael P. Rettig, Kathryn M. Trinkaus, Peter A. Riedell, Camille N. Abboud, Armin Ghobadi, Iskra Pusic, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy
Published 2020-08-01
Article -
10
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy by Francesca Ferraro, Agata Gruszczynska, Marianna B. Ruzinova, Christopher A. Miller, Mary Elizabeth Percival, Geoffrey L. Uy, Iskra Pusic, Meagan A. Jacoby, Mathew J. Christopher, Miriam Y. Kim, Peter Westervelt, Amanda F. Cashen, Mark A. Schroeder, John F. DiPersio, Camille N. Abboud, Lukas D. Wartman, Feng Gao, Daniel C. Link, Timothy J. Ley, John S. Welch
Published 2022-03-01
Article